POSC48 Cost-Effectiveness Analysis of Ferric Carboxymaltose Versus Iron Sucrose for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease in Spain
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.453
https://www.valueinhealthjournal.com/article/S1098-3015(21)02248-8/fulltext
Title :
POSC48 Cost-Effectiveness Analysis of Ferric Carboxymaltose Versus Iron Sucrose for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease in Spain
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02248-8&doi=10.1016/j.jval.2021.11.453
First page :
Section Title :
Open access? :
No
Section Order :
11225